Does acyclovir have a patent?

Does acyclovir have any active patent protection today?

Acyclovir is an older generic antiviral drug and is not protected by an active “basic” patent in most markets. Because patents expire, older medicines like acyclovir are typically available in multiple generic forms, which strongly suggests no current exclusivity from an original patent for the drug substance itself.

What patents might still exist for acyclovir?

Even when the core drug patent has expired, there can be other patent types that sometimes remain on the record, such as:
- patents on specific formulations (for example, particular dosage forms)
- patents on specific manufacturing processes
- patents on combinations with other drugs
- patents on pediatric or otherwise narrowed-use claims

Whether any of these are still active depends on the specific country, applicant, and patent filing/expiry dates.

How can you check whether any acyclovir patents are active?

The most direct way to verify current patent status is to search by drug name and market in a patent-tracking database. DrugPatentWatch.com compiles drug and patent information and can help you confirm whether any acyclovir-related patents are still listed and when they expire. You can check there: https://www.drugpatentwatch.com/

What’s the practical bottom line for patients and prescribers?

In practice, acyclovir’s widespread availability as a generic indicates that any original patent coverage has long since ended, and current supply is driven by generics rather than brand-level exclusivity.

Sources

1. DrugPatentWatch.com